| Certainty assessment | Certainty | ||||||
|---|---|---|---|---|---|---|---|
| Number
of studies (and participants) |
Study design |
Risk
of bias |
Inconsistency | Indirectness | Imprecision | Other considerations |
|
| Cardiovascular endurance (follow-up: range 4 weeks to 12 weeks) | |||||||
| 14 (345 participants) |
randomized trials |
serious |
serious |
not serious | serious |
publication bias strongly suspected |
⊕ ⃝ ⃝ ⃝ Very low |
| Power (follow-up: range 4 weeks to 8 weeks) | |||||||
| 10 (280 participants) |
randomized trials |
serious |
serious |
not serious | serious |
none | ⊕ ⃝ ⃝ ⃝ Very low |
| Change of direction ability (follow-up: range 4 weeks to 8 weeks) | |||||||
| 10 (269 participants) |
randomized trials |
serious |
serious |
not serious | serious |
none | ⊕ ⃝ ⃝ ⃝ Very low |
| Sprint (follow-up: range 4 weeks to 6 weeks) | |||||||
| 11 (253 participants) |
randomized trials |
serious |
serious |
not serious | serious |
none | ⊕ ⃝ ⃝ ⃝ Very low |
| Muscular Strength (follow-up: mean 6 weeks) | |||||||
| 1 (30 participants) |
Randomized trials |
serious |
not serious | not serious | serious |
none | ⊕⊕ ⃝ ⃝ Low |
| Muscular Endurance (follow-up: mean 8 weeks) | |||||||
| 1 (30 participants) |
randomized trials |
serious |
not serious | not serious | serious |
none | ⊕⊕ ⃝ ⃝ Low |
| Basketball performance (follow-up: range 4 weeks to 8 weeks) | |||||||
| 6 (163 participants) |
randomized trials |
serious |
serious |
not serious | serious |
none | ⊕ ⃝ ⃝ ⃝ Very low |